Peter Johnson Selected Research

Peter Johnson Research Topics

Disease

28	Neoplasms (Cancer) 01/2023 - 11/2002
11	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2023 - 05/2013
9	Lymphoma (Lymphomas) 02/2024 - 02/2007
7	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2021 - 04/2002
6	COVID-19 12/2023 - 01/2021
6	Infections 01/2023 - 02/2004
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2015 - 11/2002
5	Hodgkin Disease (Hodgkin's Disease) 04/2021 - 04/2015
4	B-Cell Lymphoma (Lymphoma, B Cell) 02/2024 - 02/2007
3	Disease Progression 02/2023 - 04/2015
3	Breakthrough Infections 01/2023 - 01/2022
3	Neutropenia 01/2019 - 05/2006
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2017 - 09/2004
3	Hypoxia (Hypoxemia) 08/2017 - 08/2004
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 08/2015 - 11/2010
2	Multiple Myeloma 06/2020 - 01/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 10/2017
2	Enteropathy-Associated T-Cell Lymphoma 05/2018 - 03/2013
2	T-Cell Lymphoma (Lymphoma, T Cell) 05/2018 - 01/2014
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 06/2017 - 02/2013
2	Breast Neoplasms (Breast Cancer) 10/2009 - 01/2007
2	Sinusitis 04/2006 - 02/2004
1	Neonatal Abstinence Syndrome 12/2023
1	Frailty 01/2023
1	Coronavirus Infections 11/2022
1	COVID-19 breakthrough infections 01/2022
1	Adenocarcinoma 01/2022
1	Cysts 10/2020
1	Progressive Multifocal Leukoencephalopathy 06/2020
1	Thrombocytopenia 3 01/2019
1	Corneal Injuries 01/2019
1	Edema (Dropsy) 01/2019
1	Dehydration (Water Stress) 12/2018

Drug/Important Bio-Agent (IBA)

15	Rituximab (Mabthera)FDA Link 02/2023 - 11/2002
8	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2021 - 05/2013
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2021 - 12/2008
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2004
6	Vincristine (Oncovin)FDA LinkGeneric 04/2021 - 05/2013
6	Monoclonal AntibodiesIBA 01/2021 - 11/2002
5	ibrutinibIBA 02/2023 - 08/2013
4	Agammaglobulinaemia Tyrosine KinaseIBA 02/2024 - 08/2013
4	VaccinesIBA 01/2023 - 01/2007
4	Prednisolone (Predate)FDA LinkGeneric 04/2021 - 05/2013
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
3	Dacarbazine (DIC)FDA LinkGeneric 04/2021 - 04/2015
3	Bleomycin (Blenoxane)FDA LinkGeneric 04/2021 - 04/2015
3	Vinblastine (Vinblastine Sulfate)FDA Link 04/2021 - 04/2015
3	Bortezomib (Velcade)FDA Link 01/2020 - 11/2010
3	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2017 - 03/2015
2	Lenalidomide (CC 5013)FDA Link 02/2023 - 01/2020
2	Etoposide (VP 16)FDA LinkGeneric 04/2021 - 03/2015
2	NivolumabIBA 01/2021 - 01/2019
2	Prednisone (Sone)FDA LinkGeneric 01/2021 - 01/2019
2	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 11/2017 - 05/2016
2	Methotrexate (Mexate)FDA LinkGeneric 11/2017 - 05/2016
2	Oxygen (Dioxygen)IBA 08/2017 - 06/2016
2	Chlorambucil (Leukeran)FDA Link 06/2017 - 02/2013
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2015 - 03/2015
2	Alemtuzumab (Campath)FDA Link 03/2015 - 10/2010
2	AntibodiesIBA 08/2013 - 02/2007
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2013 - 05/2006
2	Complement System Proteins (Complement)IBA 06/2008 - 11/2002
2	Glutamate Receptors (Glutamate Receptor)IBA 05/2007 - 11/2005
2	AntigensIBA 02/2007 - 01/2007
2	Moxifloxacin (Avelox)FDA Link 04/2006 - 02/2004
1	parsaclisibIBA 02/2024
1	Opioid Analgesics (Opioids)IBA 12/2023
1	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2023
1	SARS-CoV-2 spike proteinIBA 01/2023
1	Cell-Free Nucleic AcidsIBA 10/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Procarbazine (Matulane)FDA Link 04/2021
1	CytokinesIBA 01/2021
1	carboxyl radical (COO-)IBA 01/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	histone H3 trimethyl Lys4IBA 01/2021
1	Histones (Histone)IBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 10/2020
1	Serotonin (5 Hydroxytryptamine)IBA 10/2020
1	AlkaloidsIBA 10/2020
1	Reserpine (Serpasil)FDA Link 10/2020
1	pomalidomideIBA 01/2020
1	acalabrutinibIBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020
1	Lipase (Acid Lipase)FDA Link 01/2019
1	Aquaporin 5IBA 01/2019
1	GoldIBA 12/2018
1	Proteasome InhibitorsIBA 10/2018

Therapy/Procedure

23	Therapeutics 11/2022 - 04/2006
9	Drug Therapy (Chemotherapy) 01/2023 - 11/2002
7	Stem Cell Transplantation 02/2023 - 03/2013
4	Radiotherapy 11/2022 - 04/2015
2	Length of Stay 01/2023 - 09/2018
2	Immunotherapy 01/2016 - 08/2013
2	Transplantation 03/2015 - 10/2010
1	Neoadjuvant Therapy 01/2021
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 06/2020
1	Autologous Transplantation 01/2019
1	Home Nursing (Nursing, Home) 12/2018